Key facts
- Nimblemind’s last known valuation is $330K (Sep 2024).
- It has raised $2.5M; the latest was Early Stage VC ($2.5M) in Mar 2025.
- Notable investors include Techstars, Matter (Consulting Services (B2B)), Great Oaks Venture Capital, Bread & Butter Ventures, CSI Technology Incubator — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Nimblemind
- ·The full record, as it builds
Funding rounds
No funding rounds for Nimblemind are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nimblemind
Developer of a technology platform designed to curate and enrich healthcare data. The company's platform ingests multimodal data and outputs structured, enriched data ready for artificial intelligence training while maintaining security and compliance, enabling healthcare companies to have better clinical outcomes, more efficient administration, and optimized revenue.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2024
- Employees
- 7
- Website
- nimblemind.ai/
- Ownership
- Privately Held (backing)
Nimblemind doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nimblemind shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nimblemind in its N-PORT filings yet. We sweep new filings monthly.